Abstract
Inflammatory demyelinating polyradiculoneuropathies are a group of peripheral nerve system disorders in which immune reactions are dysregulated. Cytokines have noticeable roles in the regulation of these responses. We compared transcript levels of nine cytokine coding genes namely IL-1B, IL-2, IL-4, IL-6, IL-8, IL-17A, IFN-G, TGF-B and TNF-A in the peripheral blood of patients with acute and chronic kinds of this condition (AIDP and CIDP) and healthy persons. Expression of IL-17A was significantly lower in female AIDP cases compared with female controls (Expression Ratio = 0.02, P value = 0.02). Expression of this cytokine was higher in female CIDP cases compared with female AIDP cases (Expression ratio = 65.69, P value = 0.02). Moreover, expression of IL-6 tended to be diminished in female AIDP cases compared with normal females (Expression Ratio = 0.06, P value = 0.05). Expression of TGF-B was lower in female AIDP cases compared with female controls (Expression Ratio = 0.06, P value = 0.01). Transcript amounts of IL-1B were lower in whole CIDP cases compared with whole controls and in female AIDP cases compared with female controls (Expression Ratios = 0.09 and 0.00; P values = 0.04 and 0.01, respectively). Expression of this gene was considerably increased in female CIDP cases compared with female AIDP cases (Expression Ratio = 764.10, P value = 0.02). Finally, expression of this gene was lower in total cases compared with total controls (Expression ratio = 0.19, P value = 0.03). Diagnostic power of IL-4 was estimated to be 0.7 in differentiating between CIDP cases and controls. IL-1B had the diagnostic power of 0.72 in distinguishing between ADP cases and controls. Finally, TNF-A had the diagnostic power of 0.71 in differentiating between AIDP cases and CIDP cases. The current results suggest the possible role of these cytokines in the pathogenesis of inflammatory demyelinating polyradiculoneuropathies.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Availability of data and materials
The analyzed data sets generated during the study are available from the corresponding author on reasonable request.
References
Beppu M, Sawai S, Misawa S, Sogawa K, Mori M, Ishige T, Satoh M, Nomura F, Kuwabara S (2015) Serum cytokine and chemokine profiles in patients with chronic inflammatory demyelinating polyneuropathy. J Neuroimmunol 279:7–10
Blanco LP, Plegue M, Fung-Leung W-P, Holoshitz J (2013) Gender-biased regulation of human IL-17-producing cells in vitro by peptides corresponding to distinct HLA-DRB1 allele-coded sequences. J Immune Based Ther Vaccines Antimicrob 2:29–38
Chi LJ, Xu WH, Zhang ZW, Huang HT, Zhang LM, Zhou J (2010) Distribution of Th17 cells and Th1 cells in peripheral blood and cerebrospinal fluid in chronic inflammatory demyelinating polyradiculoneuropathy. J Peripher Nerv Syst 15:345–356
Dahle C, Kvarnström M, Ekerfelt C, Samuelsson M, Ernerudh J (2003) Elevated number of cells secreting transforming growth factor β in Guillain-Barré syndrome. APMIS 111:1095–1104
Dimachkie MM, Barohn RJ (2013) Guillain-Barré syndrome and variants. Neurol Clin 31:491–510
Frydecka D, Misiak B, Pawlak-Adamska E, Karabon L, Tomkiewicz A, Sedlaczek P, Kiejna A, Beszłej JA (2015) Sex differences in TGFB-β signaling with respect to age of onset and cognitive functioning in schizophrenia. Neuropsychiatr Dis Treat 11:575–584
Hussen BM, Nicknafs F, Hidayat HJ, Sayad A, Ghafouri-fard S & Taheri M (2021) A diagnostic panel for acquired immune-mediated polyneuropathies based on the expression of lncRNAs. Front Immunol 12
Li S, Yu M, Li H, Zhang H & Jiang Y (2012) IL-17 and IL-22 in cerebrospinal fluid and plasma are elevated in Guillain-Barré syndrome. Mediators Inflamm 260473
Ma X, Reynolds SL, Baker BJ, Li X, Benveniste EN, Qin H (2010) IL-17 enhancement of the IL-6 signaling cascade in astrocytes. J Immunol (Baltimore, Md.: 1950) 184:4898–4906
Maimone D, Annunziata P, Simone IL, Livrea P, Guazzi GC (1993) Interleukin-6 levels in the cerebrospinal fluid and serum of patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy. J Neuroimmunol 47:55–61
Meyer zuhorste G, Mausberg AK, Cordes S, El-haddad H, Partke HJ, Leussink VI, Roden M, Martin S, Steinman L, Hartung HP, Kieseier BC (2014) Thymic epithelium determines a spontaneous chronic neuritis in Icam1(tm1Jcgr)NOD mice. J Immunol 193:2678–2690
Neurology AAO (1991) Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP): report from an ad hoc subcommittee of the American Academy of Neurology AIDS Task Force. Neurology 41:617–618
Park I-K, Letterio JJ, Gorham JD (2007) TGF-beta 1 inhibition of IFN-gamma-induced signaling and Th1 gene expression in CD4+ T cells is Smad3 independent but MAP kinase dependent. Mol Immunol 44:3283–3290
Safa A, Azimi T, Sayad A, Taheri M & Ghafouri-fard S (2020) A review of the role of genetic factors in Guillain–Barré syndrome. J Mol Neurosci
Sivieri S, Ferrarini AM, Lolli F, Matà S, Pinto F, Tavolato B, Gallo P (1997) Cytokine pattern in the cerebrospinal fluid from patients with GBS and CIDP. J Neurol Sci 147:93–95
Stettner M, Lohmann B, Wolffram K, Weinberger J-P, Dehmel T, Hartung H-P, Mausberg AK, Kieseier BC (2014) Interleukin-17 impedes Schwann cell-mediated myelination. J Neuroinflammation 11:63
Svahn J, Antoine JC, Camdessanché JP (2014) Pathophysiology and biomarkers in chronic inflammatory demyelinating polyradiculoneuropathies. Rev Neurol (paris) 170:808–817
Ubogu EE (2015) Inflammatory neuropathies: pathology, molecular markers and targets for specific therapeutic intervention. Acta Neuropathol 130:445–468
van der Meché F, van Doorn P, Meulstee J, Jennekens F (2001) Diagnostic and classification criteria for the Guillain-Barré syndrome. Eur Neurol 45:133–139
Wang X, Zheng XY, Ma C, Wang XK, Wu J, Adem A, Zhu J, Zhang HL (2014) Mitigated Tregs and augmented Th17 cells and cytokines are associated with severity of experimental autoimmune neuritis. Scand J Immunol 80:180–190
Acknowledgements
The current study was supported by a grant from Shahid Beheshti University of Medical Sciences.
Funding
Not applicable.
Author information
Authors and Affiliations
Contributions
As and SGF wrote the draft and revised it. MT and FN performed the experiment. NN and MDO analyzed the data. All authors contributed equally and fully aware of submission.
Corresponding authors
Ethics declarations
Ethics approval and consent to Participant
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent forms were obtained from all study participants. The study protocol was approved by the ethical committee of Shahid Beheshti University of Medical Sciences (IR.SBMU.RETECH.REC.1398.147). All methods were performed in accordance with the relevant guidelines and regulations.
Consent of publication
Not applicable.
Competing Interest
The authors declare they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Nicknafs, F., Ghafouri-Fard, S., Omrani, M.D. et al. Expression analysis of cytokine transcripts in inflammatory demyelinating polyradiculoneuropathy. Metab Brain Dis 36, 2111–2118 (2021). https://doi.org/10.1007/s11011-021-00771-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11011-021-00771-y